CHARLOTTE, N.C. — Danaher Corporation announced Monday that it has
entered into a definitive transaction agreement to acquire Nobel Biocare Holding AG, the world
leader in implant dentistry.
Over the past 40 years, Nobel Biocare has established itself as a
pioneer in nearly every aspect of implant dentistry — from PI Brânemark’s discovery of
osseointegration, to Procera digital prosthetic solutions and treating fully edentulous patients. In
doing so, Nobel Biocare has dramatically changed the lives of millions of patients. Implants and
prosthetics are one of the most exciting categories in dentistry today, offering a unique
opportunity for dental professionals to deliver long-term solutions to women and men who
desire a smile that is both beautiful and functional.
With the ways in which technology and
materials science continue to shape the implant dentistry workflow, bringing Nobel Biocare to
the dental platform upholds Danaher’s commitment to be a world leader in dentistry.
Nobel Biocare will be a cornerstone of the dental platform. With the addition of Nobel Biocare,
Danaher will be the strongest consumable and equipment player in the dental industry, with
sales approaching $3 billion. Dental implants is a $3.5 billion market with attractive long-term
growth drivers, including an aging population, growing income in high-growth markets and low
penetration rates of dental implants in most geographies today. With this acquisition, Danaher
will have an unmatched position in dental implants with Nobel Biocare in the premium segment
and the Implant Direct joint venture in the value segment; the company plans to further invest in
both these segments.
Nobel Biocare will operate as a stand-alone company within Danaher’s
dental platform, maintaining its own brand and identity. Implant Direct will remain as a standalone
joint venture with no change in its go to market strategy.
“We will continue to invest in a wide range of dental technologies and innovations to better
serve our customers. Bringing Nobel Biocare’s deep expertise in implant dentistry, digital
prosthetics and software solutions together with our extensive knowledge in 3D imaging,
intraoral scanning and digital restorative solutions will further enable us to optimize and
integrate workflows. This will lead to better clinical outcomes, shorter treatment times and fewer
office visits to the benefit of patients and dental practitioners,” said Henk van Duijnhoven,
Senior Vice President of Danaher’s dental platform. “This combination will further support our
business strategy and position our dental business for future growth.”
Danaher’s dental platform reaches 99% of all dental practices through an extensive network of
dealer partners as well as direct sales. It will continue its strategy of working closely with its
highly valued distribution partners as well as direct sales to maximize market access for all its
brands.
“Nobel Biocare’s leadership team has done an outstanding job creating a strong platform for
future growth over the last couple of years,” van Duijnhoven added. “Our team is excited to
work with CEO Richard Laube and the Nobel Biocare team to build on their efforts toward
continued innovation, growth and business improvement. We look forward to welcoming all
Nobel Biocare’s associates, customers and key opinion leaders to the Danaher team.”
